It was polymedix and now they are in bankruptcy. They were developing a novel antibiotic and then had to sell assets. Cellceutix now bought the drug and will develop it themselves. So basically the drug is alive just that all my shares are worth shit. The other company swoops in buys the drug at a huge discount and then gets to run with it. What crap. Now gnbt is a red flag all the same...signals of trouble getting additional money to continue additional trials. If they don't get additional monies then they will go under like polymedix did. Then through bankruptcy selling assets process, some other company can buy the tech and the drugs to develop on their own. Then the option will be to buy stock of the new company.
Ugh, if only we had better news in a positive light to eliminate the extreme negative thoughts that I am having.
News 
Market Data 
Discover 
AI
